Our 2025 Impact Report is Live — See what we are building together >

Search

LogicBio Therapeutics Announces $50 Million in Financing to Develop Novel Gene Medicines for Pediatric Patients

LabCentral Gallery 1832 and Lobby Features Work Focusing on Cellular Structures by Stained Glass Artist and Biologist Joel Kowit, Ph.D.

Unum Therapeutics Announces Active Investigational New Drug (IND) Application for ACTR087 in Combination with SEA-BCMA in Patients with Relapsed/Refractory Multiple Myeloma

Science Exchange Signs on as LabCentral Sponsor to Support Life Science and Biotech Startups with Outsourced R&D Services

Read More

Stealthy Flagship cancer drug startup nabs $21M, new Kendall Square digs

Agilent Technologies Joins with LabCentral to Help Advance Scientific Discovery

Read More

LabCentral to Open Next-Stage Facility for Growing Life-Science Companies, Supported by Pfizer

In December 2017, LabCentral plans to open…
Read More

Amgen And LabCentral Open Nomination Process For Lab Residency

LogicBio Therapeutics to Present Preclinical Data at European Society of Gene & Cell Therapy 25th Anniversary Congress in Berlin

Baker-Polito Administration Awards $11.9 Million in Workforce Training Fund Grants